BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32353679)

  • 1. Ultra-sensitive quantification of the therapeutic cyclic peptide bremelanotide utilizing UHPLC-MS/MS for evaluation of its oral plasma pharmacokinetics.
    Sauter M; Uhl P; Burhenne J; Haefeli WE
    J Pharm Biomed Anal; 2020 Jul; 186():113276. PubMed ID: 32353679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra-sensitive bioanalysis of the therapeutic peptide exenatide for accurate pharmacokinetic analyses at effective plasma concentrations utilizing UPLC-MS/MS.
    Sauter M; Uhl P; Burhenne J; Haefeli WE
    J Pharm Anal; 2020 Jun; 10(3):233-239. PubMed ID: 32612869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of triple quadrupole tandem mass spectrometry to the bioanalysis of collision-induced dissociation-resistant cyclic peptides - Ultra-sensitive quantification of the somatostatin-analog pasireotide utilizing UHPLC-MS/MS.
    Sauter M; Uhl P; Burhenne J; Haefeli WE
    J Pharm Biomed Anal; 2021 Feb; 194():113728. PubMed ID: 33234413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ultra-sensitive UHPLC-MS/MS assay for the quantification of orally administered vancomycin in plasma.
    Sauter M; Uhl P; Foerster KI; Mohr I; Höne RT; Merle U; Burhenne J; Haefeli WE
    J Pharm Biomed Anal; 2019 Sep; 174():633-638. PubMed ID: 31279892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder.
    Mayer D; Lynch SE
    Ann Pharmacother; 2020 Jul; 54(7):684-690. PubMed ID: 31893927
    [No Abstract]   [Full Text] [Related]  

  • 6. Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide.
    Althof S; Derogatis LR; Greenberg S; Clayton AH; Jordan R; Lucas J; Spana C
    J Sex Med; 2019 Aug; 16(8):1226-1235. PubMed ID: 31277966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitive quantification of the somatostatin analog AP102 in plasma by ultra-high pressure liquid chromatography-tandem mass spectrometry and application to a pharmacokinetic study in rats.
    Eugster PJ; Boyle CN; Prod'hom S; Tarasco E; Buclin T; Lutz TA; Harris AG; Grouzmann E
    Drug Test Anal; 2018 Sep; 10(9):1448-1457. PubMed ID: 29745052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous Determination of Aesculin, Aesculetin, Fraxetin, Fraxin and Polydatin in Beagle Dog Plasma by UPLC-ESI-MS/MS and Its Application in a Pharmacokinetic Study after Oral Administration Extracts of
    Wang Z; Zhu W; Liu H; Wu G; Song M; Yang B; Yang D; Wang Q; Kuang H
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30205426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-extraction disulfide bond cleavage for MS/MS quantification of collision-induced dissociation-resistant cystine-cyclized peptides and its application to the ultra-sensitive UPLC-MS/MS bioanalysis of octreotide in plasma.
    Sauter M; Uhl P; Burhenne J; Haefeli WE
    Anal Chim Acta; 2020 Jun; 1114():42-49. PubMed ID: 32359513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a liquid chromatography/tandem mass spectrometry assay for the quantification of PM02734, a novel antineoplastic agent, in dog plasma.
    Yin J; Aviles P; Lee W; Ly C; Guillen MJ; Munt S; Cuevas C; Faircloth G
    Rapid Commun Mass Spectrom; 2006; 20(18):2735-40. PubMed ID: 16921565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.
    Kingsberg SA; Clayton AH; Portman D; Williams LA; Krop J; Jordan R; Lucas J; Simon JA
    Obstet Gynecol; 2019 Nov; 134(5):899-908. PubMed ID: 31599840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC-MS/TOF and UHPLC-MS/MS study of in vivo fate of rifamycin isonicotinyl hydrazone formed on oral co-administration of rifampicin and isoniazid.
    Prasad B; Singh S
    J Pharm Biomed Anal; 2010 Jul; 52(3):377-83. PubMed ID: 19692195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist.
    Diamond LE; Earle DC; Heiman JR; Rosen RC; Perelman MA; Harning R
    J Sex Med; 2006 Jul; 3(4):628-638. PubMed ID: 16839319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous Determination and Pharmacokinetics of Peimine and Peiminine in Beagle Dog Plasma by UPLC-MS/MS after the Oral Administration of
    Wang Z; Cao F; Chen Y; Tang Z; Wang Z
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29958456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A liquid chromatographic/tandem mass spectroscopic method for quantification of the cyclic peptide melanotan-II. Plasma and brain tissue concentrations following administration in mice.
    Hatziieremia S; Kostomitsopoulos N; Balafas V; Tamvakopoulos C
    Rapid Commun Mass Spectrom; 2007; 21(15):2431-8. PubMed ID: 17610239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis and pharmacokinetics studies of gastrodin and p-hydroxybenzyl alcohol in dogs using ultra fast liquid chromatography-tandem mass spectrometry method.
    Jia Y; Li X; Xie H; Shen J; Luo J; Wang J; Wang KD; Liu Q; Kong L
    J Pharm Biomed Anal; 2014 Oct; 99():83-8. PubMed ID: 25108372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bremelanotide (Vyleesi) for hypoactive sexual desire disorder.
    Med Lett Drugs Ther; 2019 Jul; 61(1577):114-116. PubMed ID: 31381550
    [No Abstract]   [Full Text] [Related]  

  • 18. Determination of geniposide in adjuvant arthritis rat plasma by ultra-high performance liquid chromatography tandem mass spectrometry method and its application to oral bioavailability and plasma protein binding ability studies.
    Chen J; Wu H; Xu GB; Dai MM; Hu SL; Sun LL; Wang W; Wang R; Li SP; Li GQ
    J Pharm Biomed Anal; 2015 Apr; 108():122-8. PubMed ID: 25771205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An evaluation of bremelanotide injection for the treatment of hypoactive sexual desire disorder.
    Cipriani S; Alfaroli C; Maseroli E; Vignozzi L
    Expert Opin Pharmacother; 2023 Jan; 24(1):15-21. PubMed ID: 36242769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of an UHPLC-ESI-QTOF-MS method for quantification of the highly hydrophilic amyloid-β oligomer eliminating all-D-enantiomeric peptide RD2 in mouse plasma.
    Hupert M; Elfgen A; Schartmann E; Schemmert S; Buscher B; Kutzsche J; Willbold D; Santiago-Schübel B
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jan; 1073():123-129. PubMed ID: 29248770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.